proxyvotesnow.com

Home › Asset managers › Blackstone Alternative Investment Funds › 2024-2025 › Against the board

Blackstone Alternative Investment Funds 2024-2025: where it broke with the board

Two kinds of vote are listed: a board-sponsored proposal Blackstone Alternative Investment Funds voted AGAINST or withheld on, and a shareholder proposal it voted FOR. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.

Everything Only shareholder proposals it backed

1,468 proposals.

Blackstone Alternative Investment Funds, 2024-2025 proxy season. Who put a proposal on the ballot is taken from its N-PX category; see the method note on the overview page.
CompanyMeetingProposalCategory On the ballot fromBlackstone Alternative Investment Funds votedFunds
1-800-FLOWERS.COM INC. 2024-12-11 Election of Directors: Celia R. Brown Director Elections Board ABSTAIN 1
1-800-FLOWERS.COM INC. 2024-12-11 Election of Directors: Christina Shim Director Elections Board ABSTAIN 1
1-800-FLOWERS.COM INC. 2024-12-11 Election of Directors: Christopher G. McCann Director Elections Board ABSTAIN 1
1-800-FLOWERS.COM INC. 2024-12-11 Election of Directors: James F. McCann Director Elections Board ABSTAIN 1
1-800-FLOWERS.COM INC. 2024-12-11 Election of Directors: Larry Zarin Director Elections Board ABSTAIN 1
1-800-FLOWERS.COM INC. 2024-12-11 Election of Directors: Leonard J. Elmore Director Elections Board ABSTAIN 1
1-800-FLOWERS.COM INC. 2024-12-11 Election of Directors: Stephanie Redish Hofmann Director Elections Board ABSTAIN 1
10X GENOMICS INC. 2025-06-03 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay Board AGAINST 1
180 LIFE SCIENCES CORP. 2024-12-27 Approval of the adoption of the Third Amendment to the 180 Life Sciences Corp. 2022 Omnibus Incentive Plan Compensation Board AGAINST 1
180 LIFE SCIENCES CORP. 2024-12-27 Election of Directors: Blair Jordan Director Elections Board ABSTAIN 1
180 LIFE SCIENCES CORP. 2024-12-27 Election of Directors: Omar Jimenez Director Elections Board ABSTAIN 1
180 LIFE SCIENCES CORP. 2024-12-27 Election of Directors: Ryan Smith Director Elections Board ABSTAIN 1
1ST SOURCE CORP. 2025-04-24 Election of Directors for terms expiring April 2028: Daniel B. Fitzpatrick Director Elections Board AGAINST 1
1ST SOURCE CORP. 2025-04-24 Election of Directors for terms expiring April 2028: John F. Affleck-Graves Director Elections Board AGAINST 1
1STDIBS.COM INC. 2025-05-08 The election of three Class I directors to serve until the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: David S. Rosenblatt Director Elections Board ABSTAIN 1
3D SYSTEMS CORP. 2025-05-16 The election of the nine directors named in the accompanying Proxy Statement: Claudia N. Drayton Director Elections Board AGAINST 1
3D SYSTEMS CORP. 2025-05-16 The election of the nine directors named in the accompanying Proxy Statement: Kevin S. Moore Director Elections Board AGAINST 1
3D SYSTEMS CORP. 2025-05-16 The election of the nine directors named in the accompanying Proxy Statement: Thomas W. Erickson Director Elections Board AGAINST 1
4D MOLECULAR THERAPEUTICS INC. 2025-06-17 Election of three Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Jacob Chacko, M.D., MBA Director Elections Board ABSTAIN 1
89BIO INC. 2025-05-28 Election of Directors: To be elected for terms expiring in 2028: Derek DiRocco, Ph.D. Director Elections Board ABSTAIN 1
8X8 INC. 2024-08-15 To approve an amendment to the 2022 Equity Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 14,000,000 shares. Compensation Board AGAINST 1
A10 NETWORKS INC. 2025-04-17 To elect five directors to serve until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Tor R. Braham Director Elections Board ABSTAIN 1
AADI BIOSCIENCE INC. 2025-02-28 Equity Plan Increase Proposal. To approve an amendment to the Aadi Bioscience, Inc. 2021 Equity Incentive (the "2021 Plan") to (i) increase the shares available for issuance under the 2021 Plan by 6,300,000 shares from 2,000,284 shares to 8,300,284 shares and (ii) increase the 2021 Plan's default annual automatic share reserve increase occurring on January 1 of each year from 4% of outstanding shares on the last day of the immediately preceding fiscal year to 5%. Compensation Board AGAINST 1
AADI BIOSCIENCE INC. 2025-02-28 The PIPE Financing Proposal. To approve, for purposes of complying with the applicable provisions of Nasdaq Listing Rule 5635, the issuance of an aggregate of 21,592,000 shares of Aadi's common stock, par value $0.0001 per share, at a price of $2.40 per share and pre-funded warrants to purchase up to an aggregate of 20,076,500 shares of Aadi's common stock at a purchase price of $2.3999 per pre-funded warrant. Capital Structure Board AGAINST 1
ACLARIS THERAPEUTICS INC. 2025-06-05 Election of Directors: William Humphries Director Elections Board ABSTAIN 1
ACLARIS THERAPEUTICS INC. 2025-06-05 To approve the Aclaris Therapeutics, Inc. 2025 Equity Incentive Plan. Compensation Board AGAINST 1
ACLARIS THERAPEUTICS INC. 2025-06-05 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this proxy card. Say-on-Pay Board AGAINST 1
ACUMEN PHARMACEUTICALS INC. 2025-06-04 To elect three Class I directors, to the Board of Directors, each to hold office until the 2028 Annual Meeting of Stockholders, and until his or her successor shall have been duly elected and qualified: Kimberlee C. Drapkin Director Elections Board ABSTAIN 1
ACUSHNET HOLDINGS CORP. 2025-06-02 Election of the following nominees for director: David Maher Director Elections Board ABSTAIN 1
ACUSHNET HOLDINGS CORP. 2025-06-02 Election of the following nominees for director: Ho Yeon (Aaron) Lee Director Elections Board ABSTAIN 1
ACUSHNET HOLDINGS CORP. 2025-06-02 Election of the following nominees for director: Keun Chang (Kevin) Yoon Director Elections Board ABSTAIN 1
ACUSHNET HOLDINGS CORP. 2025-06-02 Election of the following nominees for director: Yoon Soo (Gene) Yoon Director Elections Board ABSTAIN 1
ADAPTIMMUNE THERAPEUTICS PLC 2025-05-29 To approve our 2025 employee share option scheme, which, if approved, will take effect upon the conclusion of the Annual General Meeting. Compensation Board AGAINST 1
ADAPTIMMUNE THERAPEUTICS PLC 2025-05-29 To approve our 2025 non-employee share option scheme, which, if approved, will take effect upon the conclusion of the Annual General Meeting. Compensation Board AGAINST 1
ADAPTIMMUNE THERAPEUTICS PLC 2025-05-29 To authorize the Directors under Section 551 of the U.K. Companies Act 2006 (the "2006 Act") to allot shares or to grant rights to subscribe for or to convert any security into shares. Capital Structure Board AGAINST 1
ADAPTIMMUNE THERAPEUTICS PLC 2025-05-29 To empower the Directors to allot equity securities for cash pursuant to Section 570(1) of the 2006 Act as if Section 561(1) of the 2006 Act did not apply to that allotment. Capital Structure Board AGAINST 1
ADAPTIMMUNE THERAPEUTICS PLC 2025-05-29 To re-elect as a director, Ali Behbahani, who retires by rotation in accordance with the Articles of Association. Director Elections Board AGAINST 1
ADECOAGRO SA 2025-06-06 Approve Share Repurchase Capital Structure Board AGAINST 1
ADECOAGRO SA 2025-06-06 Elect Christian De Prati as Director Director Elections Board AGAINST 1
ADECOAGRO SA 2025-06-06 Elect Daniel Gonzalez as Director Director Elections Board AGAINST 1
ADECOAGRO SA 2025-06-06 Elect Ivo Sarjanovic as Director Director Elections Board AGAINST 1
ADECOAGRO SA 2025-06-06 Elect Juan Jose Sartori Pineyro as Director Director Elections Board AGAINST 1
ADECOAGRO SA 2025-06-06 Elect Manuela Artigas as Director Director Elections Board AGAINST 1
ADECOAGRO SA 2025-06-06 Elect Mariano Bosch as Director Director Elections Board AGAINST 1
ADICET BIO INC. 2025-06-11 To elect two class I directors, to serve for a three-year term ending at the Annual Meeting of Stockholders to be held in 2028: Katie Peng, MBA Director Elections Board ABSTAIN 1
ADICET BIO INC. 2025-06-11 To ratify, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay Board AGAINST 1
ADT INC. 2025-05-21 Advisory vote to approve the compensation of our named executive officers. Say-on-Pay Board AGAINST 1
ADVANCE AUTO PARTS INC. 2025-05-14 Election of the nine directors listed below: Carla J. Bailo Director Elections Board AGAINST 1
ADVANCE AUTO PARTS INC. 2025-05-14 Election of the nine directors listed below: Jeffrey J. Jones II Director Elections Board AGAINST 1
ADVANCE AUTO PARTS INC. 2025-05-14 Election of the nine directors listed below: Thomas W. Seboldt Director Elections Board AGAINST 1
ADVERUM BIOTECHNOLOGIES INC. 2025-06-17 Election of Class II Directors: James Scopa Director Elections Board ABSTAIN 1
ADVERUM BIOTECHNOLOGIES INC. 2025-06-17 Election of Class II Directors: Laurent Fischer, M.D. Director Elections Board ABSTAIN 1
ADVERUM BIOTECHNOLOGIES INC. 2025-06-17 Election of Class II Directors: Patrick Machado Director Elections Board ABSTAIN 1
ADVERUM BIOTECHNOLOGIES INC. 2025-06-17 To approve the amendment and restatement of the Adverum Biotechnologies, Inc. 2024 Equity Incentive Award Plan. Compensation Board AGAINST 1
ADVERUM BIOTECHNOLOGIES INC. 2025-06-17 To approve the amendment of certain outstanding stock options to reduce the exercise price per share to the closing price on the date of repricing. Compensation Board AGAINST 1
AECOM 2025-02-28 Election of Directors: Bradley W. Buss Director Elections Board AGAINST 1
AERCAP HOLDINGS NV 2025-04-16 Reelect Paul Dacier as Non-Executive Director Director Elections Board AGAINST 1
AEROVATE THERAPEUTICS INC. 2025-04-16 Elect the three Class I directors, Mark Iwicki, Timothy P. Noyes, and Donald J. Santel, to Aerovate's board of directors and to hold office until Aerovate's 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal; provided that if the Merger is consummated, the approval of Proposal No. 7 will only have an effect until the completion of the Merger because the composition of Aerovate's board of directors will be reconstituted upon completion of the Merger, in accordance with the Merger Agreement (the "Director Election Proposal" or "Proposal No. 7"): Mark Iwicki Director Elections Board ABSTAIN 1
AEROVATE THERAPEUTICS INC. 2025-04-16 To approve the Jade Biosciences, Inc. 2025 Stock Incentive Plan (the "Stock Plan Proposal" or "Proposal No. 5"); Compensation Board AGAINST 1
AG MORTGAGE INVESTMENT TRUST INC. 2025-05-05 Election of Directors: Debra Hess Director Elections Board ABSTAIN 1
AGRIFORCE GROWING SYSTEMS LTD. 2025-06-06 Approval of Equity Incentive Plan Amendment Compensation Board AGAINST 1
AIR INDUSTRIES GROUP 2025-06-26 Approval of an Amendment to the Air Industries Group 2022 Equity Incentive Plan, as Amended and Restated, to increase the number of shares of common stock available for issuance pursuant to the Plan from 650,000 shares to 900,000 shares. Compensation Board AGAINST 1
AIR INDUSTRIES GROUP 2025-06-26 Election of Directors: David J. Buonanno Director Elections Board ABSTAIN 1
AIR INDUSTRIES GROUP 2025-06-26 Election of Directors: Michael Brand Director Elections Board ABSTAIN 1
AIR INDUSTRIES GROUP 2025-06-26 Election of Directors: Michael D. Porcelain Director Elections Board ABSTAIN 1
AIR INDUSTRIES GROUP 2025-06-26 Election of Directors: Michael N. Taglich Director Elections Board ABSTAIN 1
AIR INDUSTRIES GROUP 2025-06-26 Election of Directors: Peter D. Rettaliata Director Elections Board ABSTAIN 1
AIR INDUSTRIES GROUP 2025-06-26 Election of Directors: Robert F. Taglich Director Elections Board ABSTAIN 1
AIRBNB INC. 2025-06-04 To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay Board AGAINST 1
AIRBNB INC. 2025-06-04 To elect Amrita Ahuja, Joseph Gebbia and Jeffrey Jordan as Class II Directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified: Amrita Ahuja Director Elections Board ABSTAIN 1
AKAMAI TECHNOLOGIES INC. 2025-05-14 To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares. Compensation Board AGAINST 1
AKANDA CORP. 2025-04-30 Elect Director Christopher Cooper Director Elections Board ABSTAIN 1
AKANDA CORP. 2025-04-30 Elect Director Jatinder Dhaliwal Director Elections Board ABSTAIN 1
AKANDA CORP. 2025-04-30 Elect Director Usama Chaudhry Director Elections Board ABSTAIN 1
ALECTOR INC. 2025-06-11 ELECTION OF DIRECTORS: Paula Hammond, Ph.D. Director Elections Board ABSTAIN 1
ALERUS FINANCIAL CORP. 2025-05-08 Election of Directors: John Uribe Director Elections Board ABSTAIN 1
ALERUS FINANCIAL CORP. 2025-05-08 Election of Directors: Randy L. Newman Director Elections Board ABSTAIN 1
ALLBIRDS INC. 2025-06-06 Election of Class I Director: Ann Freeman Director Elections Board ABSTAIN 1
ALLIANZ SE 2025-05-08 Approve Remuneration Policy Compensation Board AGAINST 1
ALLOGENE THERAPEUTICS INC. 2025-06-18 Election of Directors: Arie Belldegrun, M.D. Director Elections Board ABSTAIN 1
ALLOGENE THERAPEUTICS INC. 2025-06-18 Election of Directors: David Chang, M.D., Ph.D. Director Elections Board ABSTAIN 1
ALLOGENE THERAPEUTICS INC. 2025-06-18 Election of Directors: Elizabeth Barrett Director Elections Board ABSTAIN 1
ALLOVIR INC. 2025-03-12 To approve (i) the issuance of shares of common stock, par value $0.0001 per share, of AlloVir ("AlloVir common stock"), which will represent more than 20% of the shares of AlloVir common stock outstanding immediately prior to the merger, to stockholders of Kalaris Therapeutics, Inc. ("Kalaris"), pursuant to the terms of the Agreement and Plan of Merger among AlloVir, Kalaris and Aurora Merger Sub, Inc. ("Merger Sub"), dated as of November 7, 2024 (the "merger agreement"), a copy of which is attached as Annex A to the accompanying proxy statement/prospectus, and (ii) the change of control resulting from the merger, pursuant to Nasdaq Listing Rules 5635(a) and 5635(b), respectively (the "Nasdaq stock issuance proposal"); Extraordinary Transactions Board AGAINST 1
ALLOVIR INC. 2025-03-12 To approve an amendment to the AlloVir 2020 Stock Option and Grant Plan (the "2020 plan") to (i) increase the number of shares of AlloVir common stock reserved and available for future issuance under the 2020 plan by a number of shares of AlloVir common stock equal to five percent of the total number of shares of AlloVir common stock that are issued and outstanding immediately following the closing of the merger, (ii) establish a new maximum aggregate number of shares of AlloVir common stock that may be granted as incentive stock options, and (iii) extend the term of the 2020 plan to the tenth (10th) anniversary of the closing of the merger (the "2020 plan amendment proposal"); Compensation Board AGAINST 1
ALPHABET INC. 2025-06-06 Election of ten directors: Frances H. Arnold Director Elections Board AGAINST 1
ALPHABET INC. 2025-06-06 Election of ten directors: John L. Hennessy Director Elections Board AGAINST 1
ALPHABET INC. 2025-06-06 Election of ten directors: K. Ram Shriram Director Elections Board AGAINST 1
ALPHABET INC. 2025-06-06 Election of ten directors: L. John Doerr Director Elections Board AGAINST 1
ALPHABET INC. 2025-06-06 Election of ten directors: Larry Page Director Elections Board AGAINST 1
ALPHABET INC. 2025-06-06 Election of ten directors: Robin L. Washington Director Elections Board AGAINST 1
ALPHABET INC. 2025-06-06 Stockholder proposal regarding a human rights impact assessment of Al-driven targeted ad policies Human Rights or Human Capital/workforce Shareholder FOR 1
ALPHABET INC. 2025-06-06 Stockholder proposal regarding a report on Al data usage oversight Other Social Issues Shareholder FOR 1
ALPHABET INC. 2025-06-06 Stockholder proposal regarding a report on alignment of lobbying activities with child safety policies Other Social Issues Shareholder FOR 1
ALPHABET INC. 2025-06-06 Stockholder proposal regarding a report on online safety for children Other Social Issues Shareholder FOR 1
ALPHABET INC. 2025-06-06 Stockholder proposal regarding a report on the due diligence process to assess human rights risks in CAHRA Human Rights or Human Capital/workforce Shareholder FOR 1
ALPHABET INC. 2025-06-06 Stockholder proposal regarding an enhanced disclosure on climate goals Environment or Climate Shareholder FOR 1
ALPHATEC HOLDINGS INC. 2025-06-11 Approval of an amendment to our 2016 Equity Incentive Plan. Compensation Board AGAINST 1
ALPHATEC HOLDINGS INC. 2025-06-11 To elect nine persons to our Board of Directors: Mortimer Berkowitz III Director Elections Board ABSTAIN 1
ALTICE USA INC. 2025-06-11 Election of Directors: Charles Stewart Director Elections Board AGAINST 1
ALTICE USA INC. 2025-06-11 Election of Directors: David Drahi Director Elections Board AGAINST 1

Page 1 of 15 Next →

← Back to Blackstone Alternative Investment Funds 2024-2025 overview

Built 2026-09-27 from SEC Form N-PX filings.